Leukemia Research
Volume 24, Issue 4 , Pages 331-337 , April 2000

STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia

  • C. Kneitz

      Affiliations

    • Medizinische Poliklinik, University of Würzburg, Klinikstr. 6-8, D-97070 Würzburg, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-931-2017051; fax: +49-931-2017068
    • ,
  • M. Goller

      Affiliations

    • Medizinische Poliklinik, University of Würzburg, Klinikstr. 6-8, D-97070 Würzburg, Germany
    • ,
  • R. Seggewiss

      Affiliations

    • Medizinische Poliklinik, University of Würzburg, Klinikstr. 6-8, D-97070 Würzburg, Germany
    • ,
  • A. Yaman

      Affiliations

    • Medizinische Poliklinik, University of Würzburg, Klinikstr. 6-8, D-97070 Würzburg, Germany
    • ,
  • E. Serfling

      Affiliations

    • Institute of Pathology, University of Würzburg, Josef-Schneidersk. 2, D-97070 Würzburg, Germany
    • ,
  • H.P. Tony

      Affiliations

    • Medizinische Poliklinik, University of Würzburg, Klinikstr. 6-8, D-97070 Würzburg, Germany

Received 17 June 1999 ,Accepted 16 October 1999.

References 

  1. The French Cooperative Group on CLL Dighiero G, Travede P, Chevret S, Fenaux P, Chastang C, Binet JL. B-cell chronic leukemia: present status and future directions. Blood. 1991;78:1901
  2. Fournier S, Yang LP, Delespesse G, Rubio M, Biron G, Sarfati M. The two CD23 isoforms display differential regulation in chronic lymphocytic leukemia. Br. J. Haematol. 1995;89:373
  3. Fournier S, Tran ID, Suter U, Biron G, Delespesse G, Sarfati M. The in vivo expression of type b CD23 mRNA in B chronic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts. Leuk. Res. 1991;15:609
  4. Sarfati M, Fournier S, Christoffersen M, Biron G. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Leuk. Res. 1990;14:47
  5. Fournier S, Delespesse G, Rubio M, Biron G, Sarfati M. CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J. Clin. Invest. 1992;89:1212
  6. Tony HP, Brückner A, Wilhelm M. Differential signal requirement or upregulation of HLA-class-II molecules in lymphoma B cells. Hematol. Pathol. 1993;7:79
  7. DeFrance T, Aubry JP, Rousset F, Vandervliet B, Bonnefoy JY, Arai N, et al. Human recombinant IL-4 induces Fcε receptors (CD23) on normal B lymphocytes. J. Exp. Med. 1987;165:1459
  8. Leonard WJ, O’Shea JJ. Jaks and stats: biological implications. Ann. Rev. Immunol. 1998;16:293
  9. Takeda K, Kishimoto T, Akira S. STAT6: its role in interleukin-4 mediated biologic functions. J. Mol. Med. 1997;7:317
  10. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura SI, et al. Essential role of STAT 6 in IL-4 signaling. Nature. 1996;380:627
  11. Kamogawa Y, Lee HJ, Johnston JA, McMahon M, O’Garra A, Arain N. A conditionally active form of STAT 6 can mimic certain effects of IL-4. J. Immunol. 1998;161:1074
  12. Yokota A, Kikutani H, Tanaka T, Sato R, Barsumian EL, Suemura M, et al. Two species of human Fce receptor II (FceRII/CD23): tissue specific and IL-4-specific regulation of gene expression. Cell. 1988;55:611
  13. Köhler I, Alliger P, Minty A, Caput D, Ferrara P, Höll-Neugebauer B, et al. Human interleukin-13 activates the interleukin-4-dependent transcription factor NF-IL4 sharing a DNA binding motif with an interferon-g-induced nuclear binding factor. FEBS Lett. 1994;345:187
  14. Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, et al. STAT-related transcriptions factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood. 1996;87:1692
  15. Weber-Nordt RM, Egen C, Wehinger J, Goilleux-Gruart V, Mertelsmann R, Finke J. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and epstein-barr virus (EBV)-related lymphoma cell lines. Blood. 1996;88:809
  16. Schuh K, Avots A, Tony HP, Serfling E, Kneitz C. Nuclear NF-ATp is a hallmark of unstimulated B cells from B-CLL patients. Leuk. Lymph. 1996;23:583
  17. Caligaris-Cappio F, Janossy G. Surface markers in chronic lymphocytic leukemias of B cell type. Sem. Hematol. 1985;22:1
  18. Kaplan ME, Clark C. An improved rosetting assay for detection of human T lymphocytes. J. Immunol. Meth. 1974;5:131.
  19. Kneitz C, Goller M, Wilhelm M, Mehringer C, Wohlleben G, Schimpl A, et al. Inhibition of T cell/B cell interaction by B-CLL cells. Leukemia. 1998;13:98
  20. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with mini-extracts prepared from a small number of cells. Nucl. Acid Res. 1989;17:6419
  21. Köhler I, Rieber EP. Allergy associated Iε and Fcε receptor 2 (CD23b) genes activated via binding of an interleukin-4 induced transcritption factor to a novel responsive element. Eur. J. Immunol. 1993;23:3066
  22. Tony HP, Lehrnbecher T, Merz H, Sebald W, Wilhelm M. Regulation of IL-4 responsiveness in lymphoma B cells. Leuk. Res. 1991;15:911
  23. Luo HY, Hofstetter H, Banchereau J, Delespesse G. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. J. Immunol. 1991;147:2122
  24. Suter U, Texido G, Hofstetter H. Expression of human lymphocyte IgE receptor (Fc epsilon RII/CD23). Identification of the Fc epsilon RIIa promoter and its functional analysis in B lymphocytes. J. Immunol. 1989;143:3078
  25. Frank DA, Mahajan S, Ritz J. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT 3 constitutively phosphorylated on serine residues. J. Clin. Invest. 1997;100:3140
  26. Tinell SB, Jacobs-Helber SM, Sterneck E, Sawyer ST, Conrad DH. STAT6, NF-κB and c/EBP in CD23 expression and IgE production. Int. Immunol. 1998;10:1529
  27. Dinkel A, Aicher WK, Haas C, Zipfel PE, Peter HH, Eibel H. Transcription factor Egr-1 activity down-regulates Fas and CD23 expression in B cells. J. Immunol. 1997;159:2678
  28. Wen Z, Zhong Z, Darnell JEJ. Maximal activation of transcription by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell. 1995;82:241

PII: S0145-2126(99)00191-5

Leukemia Research
Volume 24, Issue 4 , Pages 331-337 , April 2000

Article Tools

* Image Usage & Resolution